Selexipag for the treatment of chronic thromboembolic pulmonary hypertension

Ogo, T; Shimokawahara, H; Kinoshita, H; Sakao, S; Abe, K; Matoba, S; Motoki, H; Takama, N; Ako, J; Ikeda, Y; Joho, S; Maki, H; Saeki, T; Sugano, T; Tsujino, I; Yoshioka, K; Shiota, N; Tanaka, S; Yamamoto, C; Tanabe, N; Tatsumi, K; Grp, SGS

Ogo, T (通讯作者),Natl Cerebral & Cardiovasc Ctr, Div Adv Med Res Pulm Hypertens, Div Pulm Circulat, Dept Cardiovasc Med, Suita, Japan.

EUROPEAN RESPIRATORY JOURNAL, 2022; 60 (1):

Abstract

Background Treatment options for inoperable chronic thromboembolic pulmonary hypertension (CTEPH) remain limited. Selexipag, an oral selective IP pros......

Full Text Link